logo

A Tale of Resilience: Actinium Pharmaceuticals Inc Amid Stock Market Turbulence

Actinium Pharmaceuticals Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $10.24 on 05/14/24 and a low of $1.03 for the same time frame on 03/04/25.

52-week price history of ATNM Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Actinium Pharmaceuticals Inc’s current trading price is -84.86% away from its 52-week high, while its distance from the 52-week low is 50.60%. The stock’s price range during the 52-week period has remained between $1.03 and $10.24. In the Healthcare sector, the company’s shares saw a trading volume of around 0.6 million for the day, which was evidently higher than the average daily volume of 0.23 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Actinium Pharmaceuticals Inc (ATNM) has experienced a quarterly rise of 27.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 48.35M and boasts a workforce of 49 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3375, with a change in price of -0.1300. Similarly, Actinium Pharmaceuticals Inc recorded 266,604 in trading volume during the last 100 days, posting a change of -7.74%.

Examining ATNM’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ATNM stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.

ATNM Stock Stochastic Average

Actinium Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 96.30%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 96.30%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 81.90% and 75.63%, respectively.

ATNM Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price gain of 23.02% this year. Over the last six months, there has been a stronger performance of -12.92%. The price of ATNM fallen by 26.02% during the last 30 days period. For the last 5-days stocks have improved 26.02%.

Most Popular